1839P Circulating tumor DNA (ctDNA) low pass whole genome sequencing (lpWGS) studies identify genomic alterations associating with taxane outcomes in prospective phase III taxane trials for metastatic castration resistant prostate cancer (mCRPC) sufferers (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.annonc.2023.09.2787
Publication URI: http://dx.doi.org/10.1016/j.annonc.2023.09.2787
Type: Journal Article/Review
Parent Publication: Annals of Oncology